Filing Details
HERON THERAPEUTICS, INC. /DE/ (NASDAQ:HRTX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:HRTX
HERON THERAPEUTICS, INC. /DE/ (HRTX) Files Quarterly Report for Q0
HERON THERAPEUTICS, INC. /DE/ (NASDAQ:HRTX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
What changed
HERON THERAPEUTICS, INC. /DE/ (NASDAQ:HRTX) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Heron Therapeutics filed its quarterly report (Form 10-Q) with the SEC on August 10, 2026.
- The company's stock trades at $0.34 per share with a market capitalization of $214.8 million.
- The quarterly report contains unaudited financial statements and management commentary on business performance, though specific revenue figures are not disclosed in this summary.
Market Context
HERON THERAPEUTICS, INC. /DE/'s stock currently trades at $0.34 with a market capitalization of $214.8M.
The 10-Q provides HERON THERAPEUTICS, INC. /DE/'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for HERON THERAPEUTICS, INC. /DE/ are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View HRTX Stock Page
Frequently Asked Questions
Where can I read HRTX's SEC filings?
Browse all filings on our HRTX SEC filings page.
What types of SEC filings does HERON THERAPEUTICS, INC. /DE/ file?
Public companies like HERON THERAPEUTICS, INC. /DE/ file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.